HODOSI - MED, s.r.o.

Moldava nad Bodvou 04501

0 studies enrolling now · 1 studies all time

What they study most

COVID-19

Studies at this site

• Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR). — Stopped early